Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: outcomes from the 4-week maximal usage trial

被引：1
|
作者：
Paller, Amy [1 ]
Jett, John E. [2 ]
Hebert, Adelaide [3 ,4 ,5 ]
Brown, Philip M. [2 ]
Butners, Victoria [2 ]
Fitzgerald, Nancy [2 ]
Delgado, Marta [6 ]
Gonzalez, Mercedes E. [7 ]
Piscitelli, Stephen C. [2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Dermavant Sci Inc, Morrisville, NC USA
[3] UTHealth McGovern, McGovern Sch Med, Houston, TX USA
[4] UTHealth McGovern, Childrens Mem Hermann Hosp, Houston, TX USA
[5] UTHealth McGovern Med Sch, Houston, TX USA
[6] RM Med Res Inc, Miami Lakes, FL USA
[7] Pediat Skin Res LLC, Miami, FL USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
atopic dermatitis; pediatrics; tapinarof; maximal usage trial;
D O I：
10.1093/bjd/ljad162.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
406
引用
收藏
页数：2
相关论文
共 38 条
  • [21] 671-Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis
    Simpson, Eric
    Silverberg, Jonathan, I
    Bissonnette, Robert
    Gold, Linda Stein
    Armstrong, April W.
    Hebert, Adelaide A.
    Serrao, Rocco T.
    Jakus, Jeannette R.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Tallman, Anna M.
    Eichenfield, Lawrence F.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [22] Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
    Eichenfield, LF
    Lucky, AW
    Boguniewicz, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) : 495 - 504
  • [23] Tapinarof cream 1% once daily for plaque psoriasis: Dermatology Life Quality Index and local tolerability scores from a long-term extension trial
    Armstrong, April W.
    Desai, Seemal R.
    Gooderham, Melinda
    Rubenstein, David S.
    Brown, Philip M.
    Tallman, Anna M.
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB208 - AB208
  • [24] ONCE-DAILY ROFLUMILAST CREAM 0.15% FOR ATOPIC DERMATITIS: POOLED RESULTS: FROM INTEGUMENT-1/2 PHASE 3 TRIALS
    Eichenfield, L.
    Boguniewicz, M.
    Simpson, E.
    Blauvelt, A.
    Gooderham, M.
    Lain, E.
    Chu, D.
    Higham, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S91 - S91
  • [25] Once-daily roflumilast cream 0.15% for atopic dermatitis: pooled results from INTEGUMENT-1/2 phase 3 trials
    Eichenfield, Lawrence F.
    Boguniewicz, Mark
    Simpson, Eric L.
    Blauvelt, Andrew
    Gooderham, Melinda
    Lain, Edward
    Chu, David H.
    Higham, Robert C.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II10 - II11
  • [26] Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial
    Gower, Richard
    Xu, JinHua
    Alam, Maryam S.
    Su, John C.
    Myers, Daniela E.
    Sanders, Paul
    Vlahos, Bonnie
    Zang, Chuanbo
    Lan, Jar
    Werth, John
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [27] ONCE-DAILY CRISABOROLE AS A LONG-TERM MAINTENANCE TREATMENT IN PARTICIPANTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS: A 52-WEEK CLINICAL TRIAL
    Gower, Richard
    Xu, JinHua
    Alam, Maryam S.
    Su, John C.
    Myers, Daniela E.
    Sanders, Paul
    Vlahos, Bonnie
    Zang, Chuanbo
    Lan, Jar
    Werth, John
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 39 - 39
  • [28] An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face
    Elewski, Boni
    CLINICS IN DERMATOLOGY, 2009, 27 (06) : S48 - S53
  • [29] HYDROCORTISONE-17-BUTYRATE (LOCOID) 0.1-PERCENT-CREAM VERSUS HYDROCORTISONE (UNIDERM) 1-PERCENT-CREAM IN THE TREATMENT OF CHILDREN SUFFERING FROM ATOPIC-DERMATITIS
    VEIEN, NK
    HATTEL, T
    JUSTESEN, O
    NORHOLM, A
    VERJANS, HL
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1984, 12 (05) : 310 - 313
  • [30] 0•03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis:: results of a randomized double-blind controlled trial
    Reitamo, S
    Harper, J
    Bos, JD
    Cambazard, F
    Bruijnzeel-Koomen, C
    Valk, P
    Smith, C
    Moss, C
    Dobozy, A
    Palatsi, R
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (03) : 554 - 562
1234